Metlife Inc (MET-PE) Stock Price & Analysis
Metlife Inc (MET-PE) rose 0.32% to USD 22.1 as of June 10, 2026 at 06:29 UTC, according to Nexqual real-time market data.
MET-PE last closed at USD 22.03; the session ranged USD 21.85–22.15 on volume of 98,659 shares. Market capitalization is —, with a 52-week range of USD 21.85–25.31 (NYQ). Source: Nexqual, June 10, 2026 at 06:29 UTC.
Key Statistics (as of June 10, 2026 at 06:29 UTC)
| Price | USD 22.1 |
|---|---|
| Change | ▲ 0.32% (up) |
| Previous Close | USD 22.03 |
| Open | USD 22.04 |
| Day Range | USD 21.85 – 22.15 |
| 52-Week Range | USD 21.85 – 25.31 |
| Volume | 98,659 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (MET-PE)
Nexqual's technical model rates MET-PE "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 06:29 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 32.43 (neutral) |
| vs SMA50 | Below (USD 22.7) |
| MACD | -0.21 (negative) |
Analyst Ratings (MET-PE)
Wall Street analysts rate MET-PE "None", per Nexqual as of June 10, 2026 at 06:29 UTC.
| Consensus Rating | None |
|---|
Earnings (MET-PE)
| Revenue Estimate | $19.51B |
|---|
Source: Nexqual, June 10, 2026 at 06:29 UTC.
Financials & Fundamentals (MET-PE)
| Total Revenue | $77.58B |
|---|---|
| Revenue Growth (YoY) | +2.70% |
| Gross Margin | +23.75% |
| Operating Margin | +9.92% |
| Profit Margin | +4.67% |
| ROE | +13.01% |
| Debt / Equity | 178.02 |
| Current Ratio | 2.09 |
| Total Cash | $27.63B |
| Total Debt | $49.49B |
| Free Cash Flow | $-17.43B |
Source: Nexqual, June 10, 2026 at 06:29 UTC.
Financial Health Score (MET-PE)
Nexqual rates Metlife Inc's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 06:29 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 24%, operating 10% |
| Balance Sheet | Weak — $27.6B cash vs $49.5B debt |
| Cash Flow | Weak — FCF negative: -$17.4B, burning cash |
| Efficiency | Mixed — ROE 13%, ROA 0.5% |
Ownership (MET-PE)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.13% |
| Shares Outstanding | 986.84M |
| Float | 537.55M |
Source: Nexqual, June 10, 2026 at 06:29 UTC.
Leadership (MET-PE)
Metlife Inc is led by John Dennis McCallion (age 51), Executive VP, CFO & Head of Investment Management, per Nexqual as of June 10, 2026 at 06:29 UTC.
| Executive VP, CFO & Head of Investment Management | John Dennis McCallion (age 51) |
|---|---|
| Regional President of U.S. Business & Head of MetLife Holdings | Ramy Tadros (age 49) |
| Executive VP & Chief Marketing Officer | Michael Roberts |
Major Backers & Investors (MET-PE)
Notable institutional backers of Metlife Inc include Invesco, GLOBAL X FUNDS-Global X U.S. Preferred ETF, Fidelity, according to Nexqual as of June 10, 2026 at 06:29 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 5.06% |
| GLOBAL X FUNDS-Global X U.S. Preferred ETF | 1.76% |
| Fidelity | 0.47% |
| Cohen & Steers Infrastructure Fund Inc | 0.32% |
| JPMorgan | 0.26% |
| Innovator ETFs Trust-Innovator S&P Investment Grade Preferred ETF | 0.13% |
| Whalerock Point Partners, LLC | 0.12% |
| Prudential Global Total Return Fd., Inc.-PGIM Global Total Return Fd. | 0.12% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 6.9% |
| State Street | 0.99% |
Source: Nexqual, June 10, 2026 at 06:29 UTC.
From Metlife Inc's Latest SEC 10-K Filing (filed 2026-02-19)
Key Strengths & Strategy (as disclosed to the SEC)
- Outside of the U.S., our subsidiaries are subject to various data protection regimes, including the General Data Protection Regulation (EU) 2016/679 ("GDPR"), which imposes strict requirements for controllers and processors of personal data and on transfers of personal data outside of the EEA to countries which have not been deemed "adequate" by the European Commission.
- We distribute our products and services primarily through our proprietary institutional client sales force and institutional client service teams for each major asset strategy.
- Group Benefits We have built a leading position in the U.S. group insurance market through long-standing relationships with many of the largest employers in the U.S.
- For retrospective experience rating, we evaluate past experience to determine our cost of providing insurance for the customer in light of any features that allow us to recoup certain losses or distribute certain gains back to the policyholder based on prior years' experience.
Partnerships
- Annual benefit renewal implementation, enrollment, and marketing costs normally elevate expenses for the Group Benefits segment in the fourth quarter. 6 Table of Contents Retirement and Income Solutions Our RIS segment, based in the U.S., provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MET-PA | MetLife, Inc. Preferred Series | USD 21.79 | ▼ 0.59% |
| ALL-PH | Allstate Corporation (The) Depo | USD 19.98 | ▲ 0.38% |
| SCHW-PD | The Charles Schwab Corporation | USD 24.2 | ▼ 0.37% |
| USB-PP | U.S. Bancorp Depositary Shares | USD 21.45 | ▼ 0.88% |
| MS-PK | Morgan Stanley Depositary Share | USD 23.49 | ▼ 0.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 06:29 UTC. This page is informational and not investment advice.